Биологическая активность
Tiragolumab is an immune checkpoint ингибитор связывание to T-клетка immunoglobulin and ITIM domain (TIGIT). Tiragolumab, alone or in combination with the PD-L1 ингибитор Atezolizumab (HY-P9904), may be effective against multiple solid malignancies-most notably non-small клетка lung cancer (NSCLC).
Оригинал на английском
Tiragolumab is an immune checkpoint inhibitor binding to T-cell immunoglobulin and ITIM domain (TIGIT). Tiragolumab, alone or in combination with the PD-L1 inhibitor Atezolizumab (HY-P9904), may be effective against multiple solid malignancies-most notably non-small cell lung cancer (NSCLC).
Химические свойства
- CAS №
- 1918185-84-8 pH value: Corresponds to reference standard: PASS Non-reduced CE-SDS: >95% SEC-HPLC: >95% Isoelectric Point: Corresponds to reference standard Osmolality: Corresponds to reference standard: PASS Peptide mapping: Corresponds to reference standard: PASS N-terminal sequence: Corresponds to reference standard: PASS
Безопасность и документация
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.